Luxturna
| Name | Luxturna |
|---|---|
| Active Substance | voretigene neparvovec |
| Prescription | na recept |
| Type of prescription | ograničeni recept |
| Distribution | u ljekarni |
| Medicinal product marketed in the Croatia | Da |
| Educational materials for healthcare professionals |
Luxturna kirurški priručnik, verzija 2 Luxturna ljekarnički priručnik, verzija 2 |
| Educational materials for patients / caregivers |
LUXTURNA Kartica za bolesnike, audio zapis LUXTURNA Kartica za bolesnike, verzija 1 LUXTURNA Kartica za bolesnike, verzija 1, veliki font |
Note
The medicinal product has been authorised via centralised procedure in all Member States of the European Union based on the European Medicines Agency's expert opinion. Additional information on the medicinal product can be found under the following link:https://www.ema.europa.eu/en/medicines/human/EPAR/luxturna
The marketing authorisation has been granted by the European Commission. All marketing authorisations of the European Commission can be found under the following link: http://ec.europa.eu/health/documents/community-register/html/index_en.htm
